- Home
- PLUR vs HOWL Comparison
PLUR vs HOWL Comparison
Compare PLUR & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- HOWL
- Stock Information
- Founded
- PLUR 2001
- HOWL 2017
- Country
- PLUR Israel
- HOWL United States
- Employees
- PLUR N/A
- HOWL N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- PLUR Health Care
- HOWL Health Care
- Exchange
- PLUR Nasdaq
- HOWL Nasdaq
- Market Cap
- PLUR 41.9M
- HOWL 47.1M
- IPO Year
- PLUR N/A
- HOWL 2021
- Fundamental
- Price
- PLUR $4.82
- HOWL $1.17
- Analyst Decision
- PLUR Strong Buy
- HOWL Strong Buy
- Analyst Count
- PLUR 1
- HOWL 3
- Target Price
- PLUR $12.00
- HOWL $8.33
- AVG Volume (30 Days)
- PLUR 11.2K
- HOWL 263.5K
- Earning Date
- PLUR 09-17-2025
- HOWL 08-15-2025
- Dividend Yield
- PLUR N/A
- HOWL N/A
- EPS Growth
- PLUR N/A
- HOWL N/A
- EPS
- PLUR N/A
- HOWL N/A
- Revenue
- PLUR $1,034,000.00
- HOWL $1,143,000.00
- Revenue This Year
- PLUR $472.39
- HOWL N/A
- Revenue Next Year
- PLUR $254.29
- HOWL N/A
- P/E Ratio
- PLUR N/A
- HOWL N/A
- Revenue Growth
- PLUR 203.23
- HOWL N/A
- 52 Week Low
- PLUR $3.33
- HOWL $0.60
- 52 Week High
- PLUR $7.13
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- PLUR 43.52
- HOWL 42.82
- Support Level
- PLUR $4.69
- HOWL $1.15
- Resistance Level
- PLUR $5.29
- HOWL $1.29
- Average True Range (ATR)
- PLUR 0.24
- HOWL 0.09
- MACD
- PLUR -0.06
- HOWL -0.02
- Stochastic Oscillator
- PLUR 15.75
- HOWL 15.87
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.